SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: March 25, 2006
AcuNetx, Inc.
-------------
(Exact name of the Company as specified in its charter)
Nevada 0-27857 88-0249812
---------------------------- ------------ ------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1000 S. McCaslin Blvd., Suite 300
Superior, CO 80027
------------------
(Address of principal executive offices)
The Company's telephone number, including area code:
----------------------------------------------------
(303) 494-1681
SECTION 1--REGISTRANT'S BUSINESS AND OPERATIONS
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On May 25, 2006 the Company executed a new Marketing and Distribution
Agreement with MedTrak Technologies, Inc. ("MedTrak"). MedTrak has been the
exclusive distributor of the Company's videonystagmography (VNG) and balance
products for several years. The new agreement restructures the Company's
relationship with MedTrak into a nonexclusive one, so that the Company will be
in a position to manufacture and sell VNG products under its own brand names, as
well as through MedTrak.
The agreement also changes the relationship between the Company and
Medtrak so that, in general, the Company will ship the MedTrak branded products
directly to the end-user, receive payment from the end-user, and pay MedTrak a
commission on sales.
The Agreement is for a period of eight years, and provides for
successive three year options.
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
AcuNetx, Inc., a Nevada corporation
By: /s/ Terry Knapp, Chief Executive Officer
----------------------------------------
Terry Knapp, Chief Executive Officer
Date: May 30, 2006